S2Medical AB Company Description
S2Medical AB (publ) develops products for wound healing, infection control, and cosmeceuticals spectrum in Sweden.
The company offers odor eliminator under the YNOLENS brand; IvaQ, a negative pressure wound therapy (NPWT) system; Instagraft, a technology designed to make skin transplantation even in non-specialist healthcare setting; ADMERCIN, a solution against antibiotic-resistant bacteria; and Epiprotect, a technology designed to protect and support wound healing by creating an environment for tissue recovery.
It also provides Symbiovance, a peptide-based functional skincare; Eyracure, a light-activated peptide technology that repairs damaged hair at the molecular level; and Eiratex, a biosynthetic polymer for wound healing applications.
In addition, the company distributes instaQrett; skin substitutes under the EPIPROTECT brand; and BIOPAD, an ivory-white soft sponge.
The company was incorporated in 2013 and is headquartered in Linköping, Sweden.
| Country | Sweden |
| Founded | 2013 |
| Industry | Orthopedic, Prosthetic, and Surgical Appliances and Supplies |
| Employees | 7 |
| CEO | Petter Sivler |
Contact Details
Address: Sunnorpsgatan 5 Linköping, 582 73 Sweden | |
| Phone | 46 87 00 00 50 |
| Website | s2m.se |
Stock Details
| Ticker Symbol | S21 |
| Exchange | Frankfurt Stock Exchange |
| Share Class | Class B Shares |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Petter Sivler | Chief Executive Officer |
| Marten Skog | Chief Operating Officer |